Active Biotech AB Financial Flexibility Index
Active Biotech AB financial flexibility index. Active Biotech AB (ACTI) has a Financial Flexibility Index of -0.84x as of June 2026. Free cash flow of Skr-9.00 Million (operating CF Skr-9.00 Million minus capex Skr0.00) represents -1% of total liabilities (Skr10.70 Million). See Active Biotech AB (ACTI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Active Biotech AB (2002–2025)
Financial flexibility index of Active Biotech AB from 2002 to 2025. Historical Financial Flexibility Index trend for Active Biotech AB across 24 annual periods. Check Active Biotech AB (ACTI) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Active Biotech AB Financial Flexibility Index by Year (2002–2025)
Active Biotech AB financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for Active Biotech AB. For the full cash flow conversion analysis, see cash efficiency ratio of Active Biotech AB.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-32.40 Million | Skr14.60 Million | ▲ +100.0% |
| 2024 | -3.63x | Skr-40.40 Million | Skr-40.40 Million | Skr11.13 Million | ▼ -6.2% |
| 2023 | -3.42x | Skr-45.74 Million | Skr-45.74 Million | Skr13.38 Million | ▼ -3.3% |
| 2022 | -3.31x | Skr-54.60 Million | Skr-54.85 Million | Skr16.49 Million | ▲ +27.4% |
| 2021 | -4.56x | Skr-46.17 Million | Skr-46.17 Million | Skr10.13 Million | ▼ -42.1% |
| 2020 | -3.21x | Skr-32.22 Million | Skr-32.22 Million | Skr10.04 Million | ▼ -18.0% |
| 2019 | -2.72x | Skr-35.81 Million | Skr-35.81 Million | Skr13.17 Million | ▼ -1335.0% |
| 2018 | -0.19x | Skr-40.65 Million | Skr-40.65 Million | Skr214.52 Million | ▲ +7.7% |
| 2017 | -0.21x | Skr-46.45 Million | Skr-46.45 Million | Skr226.14 Million | ▲ +35.3% |
| 2016 | -0.32x | Skr-73.16 Million | Skr-73.16 Million | Skr230.32 Million | ▲ +60.8% |
| 2015 | -0.81x | Skr-217.89 Million | Skr-217.89 Million | Skr268.84 Million | ▲ +3.1% |
| 2014 | -0.84x | Skr-265.19 Million | Skr-267.09 Million | Skr317.21 Million | ▼ -196.4% |
| 2013 | -0.28x | Skr-102.20 Million | Skr-102.25 Million | Skr362.40 Million | ▲ +58.1% |
| 2012 | -0.67x | Skr-240.38 Million | Skr-240.40 Million | Skr356.82 Million | ▼ -417.1% |
| 2011 | -0.13x | Skr-46.44 Million | Skr-46.97 Million | Skr356.53 Million | ▲ +78.7% |
| 2010 | -0.61x | Skr-196.23 Million | Skr-196.32 Million | Skr321.34 Million | ▲ +15.8% |
| 2009 | -0.73x | Skr-224.70 Million | Skr-224.77 Million | Skr309.86 Million | ▼ -43.2% |
| 2008 | -0.51x | Skr-156.61 Million | Skr-159.46 Million | Skr309.34 Million | ▲ +18.6% |
| 2007 | -0.62x | Skr-186.61 Million | Skr-186.70 Million | Skr299.97 Million | ▼ -149.9% |
| 2006 | -0.25x | Skr-100.10 Million | Skr-100.13 Million | Skr402.04 Million | ▲ +48.0% |
| 2005 | -0.48x | Skr-187.28 Million | Skr-192.51 Million | Skr391.05 Million | ▲ +51.8% |
| 2004 | -0.99x | Skr-149.58 Million | Skr-149.65 Million | Skr150.59 Million | ▲ +80.8% |
| 2003 | -5.17x | Skr-288.76 Million | Skr-288.83 Million | Skr55.82 Million | ▼ -54.9% |
| 2002 | -3.34x | Skr-291.31 Million | Skr-291.71 Million | Skr87.24 Million | — |